CR20170236A - Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método - Google Patents

Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método

Info

Publication number
CR20170236A
CR20170236A CR20170236A CR20170236A CR20170236A CR 20170236 A CR20170236 A CR 20170236A CR 20170236 A CR20170236 A CR 20170236A CR 20170236 A CR20170236 A CR 20170236A CR 20170236 A CR20170236 A CR 20170236A
Authority
CR
Costa Rica
Prior art keywords
pharmaceutical administration
administration system
calcium carbonate
producing
system obtained
Prior art date
Application number
CR20170236A
Other languages
English (en)
Inventor
Maxim Puchkov
Tanja Stirnimann
Susanna Atria
Jörg Huwyler
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of CR20170236A publication Critical patent/CR20170236A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

La presente invención se refiere a un método para la producción de un sistema de administración farmacéutica, al uso de un carbonato de calcio reaccionado en superficie para mejorar la friabilidad de un sistema de administración farmacéutica al igual que para mejorar la capacidad de flujo de un sistema de administración farmacéutica, y a un sistema de administración farmacéutica obtenido por el método
CR20170236A 2014-12-18 2015-12-16 Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método CR20170236A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP14199037.4A EP3034070A1 (en) 2014-12-18 2014-12-18 Method for the production of a pharmaceutical delivery system
US201462095865P 2014-12-23 2014-12-23
US201562232516P 2015-09-25 2015-09-25
PCT/EP2015/080016 WO2016096997A1 (en) 2014-12-18 2015-12-16 Method for the production of a pharmaceutical delivery system

Publications (1)

Publication Number Publication Date
CR20170236A true CR20170236A (es) 2017-09-26

Family

ID=52338877

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20170236A CR20170236A (es) 2014-12-18 2015-12-16 Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método

Country Status (18)

Country Link
US (1) US20190022012A1 (es)
EP (2) EP3034070A1 (es)
JP (1) JP2017538733A (es)
KR (1) KR20170098894A (es)
CN (1) CN107106498A (es)
AR (1) AR103077A1 (es)
AU (1) AU2015367524B2 (es)
BR (1) BR112017012665A2 (es)
CA (1) CA2969763A1 (es)
CO (1) CO2017005500A2 (es)
CR (1) CR20170236A (es)
MX (1) MX2017007880A (es)
PH (1) PH12017501035A1 (es)
RU (1) RU2693491C2 (es)
SG (1) SG11201704513VA (es)
TW (1) TW201627009A (es)
UY (1) UY36444A (es)
WO (1) WO2016096997A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3260114A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260115A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275537A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
EP3982935A1 (en) 2019-06-17 2022-04-20 DSM IP Assets B.V. Composition comprising metformin hci, vitamin b12 and at least one flow additive
US20210059932A1 (en) * 2019-08-28 2021-03-04 Vincent Langlois Multi-layer edible strip containing active medicinal ingredients
CN111419815B (zh) * 2020-04-23 2022-03-11 永信药品工业（昆山）股份有限公司 依托考昔片及其优化方法
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
GB202007670D0 (en) * 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
CN113413388B (zh) * 2021-06-30 2022-11-15 上海奥全生物医药科技有限公司 含有枸橼酸西地那非的药物组合物、制备方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (es) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
DK162986A (da) 1985-04-12 1986-10-13 Forest Laboratories Terapeutisk middel i enhedsdosisform
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
DE69428707T2 (de) 1993-08-20 2002-07-11 Nippon Shinyaku Co., Ltd. Im magen verbleibende zubereitung, quellender formkörper und herstellungsverfahren
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
CN1264574C (zh) * 2000-09-06 2006-07-19 田边制药株式会社 口服制剂
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
DK2070991T3 (da) 2007-12-12 2010-12-20 Omya Development Ag Fremgangsmåde til frembringelse af overflademodificeret, udfældet calciumcarbonat
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
SI2264108T1 (sl) 2009-06-15 2012-06-29 Omya Development Ag Postopek za pripravo površinsko reakcijsko obdelanega kalcijevega karbonata ob uporabi šibke kisline
ES2384017T3 (es) 2009-06-15 2012-06-28 Omya Development Ag Proceso para preparar carbonato de calcio que reacciona en la superficie y su uso
DK2679638T3 (en) 2012-06-28 2015-12-14 Omya Int Ag High solids aqueous mineral and / or filler and / or pigment suspension in an acidic pH environment
ES2536836T3 (es) 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
SI2719373T1 (sl) * 2012-10-12 2017-07-31 Omya International Ag Hitro razpadna trdna formulacijska dozirna oblika, ki vsebuje funkcionaliziran kalcijev karbonat in postopek za njeno izdelavo
ES2645223T3 (es) * 2013-06-06 2017-12-04 Zentiva, K.S. Formulaciones de agomelatina que comprenden agomelatina en forma de co-cristales
RU2646113C1 (ru) * 2016-09-06 2018-03-01 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ получения системы доставки фрагментов нуклеиновых кислот в клетки млекопитающих

Also Published As

Publication number Publication date
AR103077A1 (es) 2017-04-12
RU2693491C2 (ru) 2019-07-03
CA2969763A1 (en) 2016-06-23
CO2017005500A2 (es) 2017-09-29
KR20170098894A (ko) 2017-08-30
RU2017125320A3 (es) 2019-01-18
PH12017501035A1 (en) 2018-03-05
EP3233062A1 (en) 2017-10-25
RU2017125320A (ru) 2019-01-18
JP2017538733A (ja) 2017-12-28
US20190022012A1 (en) 2019-01-24
EP3034070A1 (en) 2016-06-22
CN107106498A (zh) 2017-08-29
AU2015367524A1 (en) 2017-07-20
MX2017007880A (es) 2017-09-05
TW201627009A (zh) 2016-08-01
AU2015367524B2 (en) 2018-03-15
BR112017012665A2 (pt) 2017-12-26
UY36444A (es) 2016-04-29
WO2016096997A1 (en) 2016-06-23
SG11201704513VA (en) 2017-07-28

Similar Documents

Publication Publication Date Title
CR20170236A (es) Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
CR20160450A (es) Anticuerpos multiespecificos
BR112016012129A8 (pt) métodos para produção, expansão e purificação de células epiteliais do pigmento da retina, composição farmacêutica e uso das células
MX2016010263A (es) Composiciones estabilizadas de silicato y su uso como composiciones antitranspirantes.
CL2016003054A1 (es) Método para la producción de gránulos que comprenden carbonato de calcio de reacción superficial.
MX2018002318A (es) Proceso mejorado para producir fucoxantina y/o polisacaridos de microalgas.
CO2017002472A2 (es) Formulación de acetato de abiraterona
FI20140266A7 (fi) Menetelmä ja laite nanopartikkeleiden valmistamiseksi
BR112018010605A2 (pt) nanoemulsões de bebidas produzidas por processamento de alto cisalhamento
MX377149B (es) Microorganismo recombinante para la produccion mejorada de productos quimicos finos.
MX384182B (es) Microorganismo recombinante para la produccion mejorada de quimicos finos.
MX2016014227A (es) Estabilizante para procesos de produccion de poliol polimerico.
MX376905B (es) Metodo para preparar bifenilaminas a partir de azobencenos mediante catalisis de rutenio.
MX387903B (es) Proceso para la preparacion de acidos 3-hidroxipicolinicos.
BR112017008854A2 (pt) partículas de cadotrila
CY1120812T1 (el) Υποκατεστημενα παραγωγα αζασπειρο(4.5)δεκανιου
UY36064A (es) Derivados quirales de ácido ciclopentancarboxílico 2,5-disustituidos y su uso
BR112015027977A2 (pt) método para a produção de formulações de óleo, formulações de óleo, e uso das formulações de óleo
DOP2017000264A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio
MX389640B (es) Método para producir dipropionato de calcio.
BR112017010403A2 (pt) método para a produção de praziquantel
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
CO2017006953A2 (es) Proceso mejorado para la producción de carbonato de calcio precipitado
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.